InsidersTradesSigma
Follow the Mankind Pharma Limited stock price and the full directors' dealings record of the company, a listed equity based in India. Shares are quoted on IN IN, under the authority of SEBI (PIT + SAST). Operating in the Health Care sector, Mankind Pharma Limited has logged 3 public disclosures. Market capitalisation: €980.9bn. The latest transaction was reported on 9 February 2024 (Sale). Among the most active insiders: Arjun Juneja. All data is accessible without an account.
Analysts rate Mankind Pharma Limited Buy (bullish), based on 20 analysts. Average price target: ₹2,653.40.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
3 of 3 declarations